END 7-OH Act
Sponsored By: Representative Bilirakis
Introduced
Summary
Designates synthetic 7‑hydroxymitragynine and its synthetic equivalents as Schedule I while excluding naturally occurring 7‑hydroxymitragynine in the kratom plant. This bill would add a new entry to Schedule I of the Controlled Substances Act and make clear that synthetic forms and analogs are covered by that schedule while the compound as it exists naturally in Mitragyna speciosa (kratom) is not scheduled by this specific entry.
Show full summary
- Producers and researchers working with synthetic 7‑hydroxymitragynine or its synthetic equivalents would be subject to Schedule I controls under the existing 21 U.S.C. 812(c) framework, because the bill adds those substances to the Schedule I list.
- Kratom growers, sellers, and consumers would not have naturally occurring 7‑hydroxymitragynine in the plant scheduled under this new entry, since the text explicitly excludes plant‑derived 7‑hydroxymitragynine from the listing.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Synthetic kratom chemical moved to Schedule I
This bill would add 7-hydroxymitragynine to Schedule I of the Controlled Substances Act. The entry would cover 7-hydroxymitragynine and its synthetic equivalents and analogs. It would expressly not apply to 7-hydroxymitragynine that is naturally contained in the kratom plant (Mitragyna speciosa Korth). If enacted, making, selling, or possessing the covered synthetic forms would be subject to federal Schedule I controls and enforcement.
Sponsors & CoSponsors
Sponsor
Bilirakis
FL • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov